AVEO Oncology
AVEO
#7007
Rank
A$0.74 B
Marketcap
A$21.48
Share price
0.00%
Change (1 day)
143.78%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$76.39 Million a decrease over its 2020 earnings that were of -A$50.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-46.64%
2021 -A$76.39 Million49.9%
2020 -A$50.96 Million-479.04%
2019 A$13.44 M-276.17%
2018 -A$7.64 Million-91.79%
2017 -A$92.98 Million142.38%
2016 -A$38.36 Million78.51%
2015 -A$21.49 Million-71.55%
2014 -A$75.53 Million-50.72%
2013 -A$0.16 Billion-4.88%
2012 -A$0.17 Billion-426.29%
2011 A$49.38 M-159.85%
2010 -A$82.52 Million35.33%
2009 -A$60.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$32.22 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.80 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.72 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.49 B-18,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.50 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.24 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA